Clinical Trial Site
Colorado Springs, Colorado 80918
1 studies enrolling now · 4 studies all time
What they study most
Generalized Myasthenia Gravis, Hearing Loss, Sensorineural, High Cardiovascular Risk, Hypertension, Noise Induced Hearing Loss, Sensorineural Hearing Loss, Sudden Hearing Loss, Sudden Sensorineural Hearing Loss
Studies at this site
- Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
- Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
- FX-322 in Adults With Stable Sensorineural Hearing Loss — Completed
- FX-322 in Adults With Acquired Sensorineural Hearing Loss — Completed